OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 245 citing articles:

Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease
Dominic P. Del Re, Dulguun Amgalan, Andreas Linkermann, et al.
Physiological Reviews (2019) Vol. 99, Iss. 4, pp. 1765-1817
Open Access | Times Cited: 743

The NLRP3 inflammasome in acute myocardial infarction
Stefano Toldo, Antonio Abbate
Nature Reviews Cardiology (2017) Vol. 15, Iss. 4, pp. 203-214
Closed Access | Times Cited: 533

The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
Nikolaos G. Frangogiannis
Circulation Research (2019) Vol. 125, Iss. 1, pp. 117-146
Open Access | Times Cited: 404

Obesity, Hypertension, and Cardiac Dysfunction
Alan J. Mouton, Xuan Li, Michael E. Hall, et al.
Circulation Research (2020) Vol. 126, Iss. 6, pp. 789-806
Open Access | Times Cited: 387

Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy
Stanley Nattel, Jordi Heijman, Liping Zhou, et al.
Circulation Research (2020) Vol. 127, Iss. 1, pp. 51-72
Open Access | Times Cited: 304

Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Anis Hanna, Nikolaos G. Frangogiannis
Cardiovascular Drugs and Therapy (2020) Vol. 34, Iss. 6, pp. 849-863
Open Access | Times Cited: 292

Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Sumita Mishra, David A. Kass
Nature Reviews Cardiology (2021) Vol. 18, Iss. 6, pp. 400-423
Open Access | Times Cited: 288

Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
Boju Sun, Li Wu, You Wu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 229

Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation
Jordi Heijman, Azinwi Phina Muna, Tina Veleva, et al.
Circulation Research (2020) Vol. 127, Iss. 8, pp. 1036-1055
Open Access | Times Cited: 215

Targeting the NLRP3 inflammasome in cardiovascular diseases
Stefano Toldo, Eleonora Mezzaroma, Leo F. Buckley, et al.
Pharmacology & Therapeutics (2021) Vol. 236, pp. 108053-108053
Open Access | Times Cited: 191

Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase
Ling Xiao, Joe‐Elie Salem, Sebastian Clauß, et al.
Circulation (2020) Vol. 142, Iss. 25, pp. 2443-2455
Open Access | Times Cited: 179

Immune Cells and Immunotherapy for Cardiac Injury and Repair
Joel G. Rurik, Haig Aghajanian, Jonathan A. Epstein
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1766-1779
Open Access | Times Cited: 176

Inflammasomes as therapeutic targets in human diseases
Yangxin Li, Hui Huang, Bin Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 168

NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases
Yucheng Wang, Xiaoxiao Liu, Hui Shi, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 1, pp. 91-106
Open Access | Times Cited: 157

Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
Dobromir Dobrev, Jordi Heijman, Roddy Hiram, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 3, pp. 145-167
Open Access | Times Cited: 150

The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
Stefano Toldo, Antonio Abbate
Nature Reviews Cardiology (2023) Vol. 21, Iss. 4, pp. 219-237
Closed Access | Times Cited: 128

Inhibition of the NLRP3/IL‐1β axis protects against sepsis‐induced cardiomyopathy
Katharina Büsch, Melanie Kny, Nora Huang, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 6, pp. 1653-1668
Open Access | Times Cited: 111

NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload
Yasutomi Higashikuni, Wenhao Liu, Genri Numata, et al.
Circulation (2022) Vol. 147, Iss. 4, pp. 338-355
Open Access | Times Cited: 97

Inflammasome Signaling in Atrial Fibrillation
Amir Ajoolabady, Stanley Nattel, Gregory Y.H. Lip, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 23, pp. 2349-2366
Open Access | Times Cited: 76

Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation
Yuan Yao, Fan Li, Mao Zhang, et al.
Circulation Research (2022) Vol. 130, Iss. 6, pp. 887-903
Open Access | Times Cited: 75

The role of inflammasomes in human diseases and their potential as therapeutic targets
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 61

Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44

Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR‐141‐mediated NLRP3 inflammasome and TGF‐β1/Smads signaling in diabetic cardiomyopathy
Hui Che, Yueqiu Wang, Hui Li, et al.
The FASEB Journal (2020) Vol. 34, Iss. 4, pp. 5282-5298
Closed Access | Times Cited: 132

Trimethylamine N-Oxide Exacerbates Cardiac Fibrosis via Activating the NLRP3 Inflammasome
Xueling Li, Jin Geng, Jinxuan Zhao, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 114

Page 1 - Next Page

Scroll to top